| Filed On | Filing |
|---|---|
| 21 Jul 2022 |
Form 4/A: Kewalramani Reshma, Director
Holds 111,287 shares of Common Stock |
| 14 Feb 2020 |
Form 4/A: Leiden Jeffrey M, Director
Received 110,472 shares as a grant or award |
| 06 Dec 2017 |
Form 4/A: Arbuckle Stuart A, EVP\Chief Commercial Officer
Sold 48 shares ($7.07K) |
| 01 Jun 2012 |
Form 4/A: Wysenski Nancy, EVP, Chief Commercial Officer
Sold 180,000 shares ($11.6M) |
| 07 Aug 2008 |
Form 4/A: Boger Joshua S, Director
Received 12,400 shares by exercise or conversion ($126K) · Sold 12,400 shares ($407K) |
| 15 Dec 2006 |
Form 4/A: Alam John J, EVP, Medicines Dev. & CMO
Received 1,500 shares by exercise or conversion ($23K) · Sold 1,980 shares ($76.5K) |
| 21 Dec 2005 |
Form 4/A: Smith Ian F, SVP & CFO
Sold 11,811 shares ($329K) |
| 05 Dec 2005 |
Form 4/A: Ullian Elaine, Director
Sold 600 shares ($15K) |
Loading...
